Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sandoz gets EMA Committee positive opinion for breast, gastric cancer biosimilar trastuzumab

Ruchika Sharma19 Sept 2023 12:30 PM IST

Basel: Sandoz has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a...

Biocon names Peter Bains as Group CEO

Ruchika Sharma19 Sept 2023 11:27 AM IST

Bengaluru: Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced, that its Board has approved the appointment of Mr Peter...

Pfizer discontinues development of danuglipron for chronic weight management

Pfizer forecasts 24 percent COVID vaccination rate in US this year

Ruchika Sharma19 Sept 2023 10:00 AM IST

New York: Pfizer expects 24% of the U.S. population, or about 82 million people, to receive COVID-19 shots this year, CFO David Denton said at a...

Torrent Pharma to Raise Up to Rs 12,500 Cr via Bonds for JB Chemicals Deal

Torrent Pharma in talks with CVC, Bain Capital for Cipla bid: Sources

Ruchika Sharma18 Sept 2023 4:37 PM IST

The second source said Cipla is likely to be more keen on getting a strategic partner on board, like Torrent, instead of a pure financial investor,...

GE HealthCare, Mayo Clinic collaborate to advance innovation in medical imaging, theranostics

Ruchika Sharma18 Sept 2023 1:30 PM IST

Rochester: Mayo Clinic and GE HealthCare have announced a strategic healthcare collaboration for research and product development programs aimed...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis Kisqali reduced cancer recurrence risk while maintaining quality of life in patients diagnosed with early breast cancer

Ruchika Sharma18 Sept 2023 12:30 PM IST

Basel: Novartis has presented new patient-reported outcomes (PRO) data from the Phase III NATALEE trial at the European Society for Medical Oncology...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck gets positive EU CHMP opinion for Keytruda as adjuvant treatment for adults with Non-Small Cell Lung Cancer

Ruchika Sharma18 Sept 2023 11:30 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers plans to double experimental treatments to expand research pipeline

Ruchika Sharma17 Sept 2023 3:00 PM IST

New York: Bristol Myers Squibb has said it plans to double the number of treatments it is testing in clinical trials, with a focus on cell therapies,...

Insud Pharma inaugrates Oligonucleotides Centre in India

Ruchika Sharma17 Sept 2023 1:00 PM IST

This new plant will be capable of producing a novel antisense Oligonucleotide for the treatment of Spinal Muscular Atrophy.

Moderna updated COVID vaccine approved by UK regulator

Ruchika Sharma17 Sept 2023 11:30 AM IST

United Kingdom: The UK drug regulator has said it has approved an updated COVID-19 vaccine by Moderna, making it the second shot to be used in the...

State-Wide Immunization Drive in Haryana Targets High-Risk Areas

US NIH starts human trials of universal flu vaccine

Ruchika Sharma17 Sept 2023 10:00 AM IST

FluMos-v2 has been designed by researchers at NIAID's Vaccine Research Center.

Pfizer USD 43 billion bid for Seagen to be decided by EU antitrust regulators

Ruchika Sharma16 Sept 2023 4:11 PM IST

Brussels: Pfizer's $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok